SOCS3 and chronic myelogenous leukemia, BCR-ABL1 positive: Previous studies demonstrated that the expression of SOCS3 was associated with the response of CML cells to IFN-alpha [16, 17], and down-regulation of SOCS3 was a possible reason for imatinib resistance of leukemia cells [11].